Home Industries Market Insights About Us Publisher Contact us

Mechanical Thrombectomy Devices Market Size, Share & Trends Analysis Report By Application (Cardiovascular, Neurovascular, And Peripheral Vascular Applications), By End-user (Hospitals And Surgical Centers, Ambulatory Care Centers, And Research Laboratories & Academic Institutes), Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America)—Forecast till 2028

Categories: Life Science   |   Formate :

Global Mechanical Thrombectomy Devices Market was valued at USD 982 million in 2016. This value is projected to reach USD 1.38 billion by 2022 at a growing CAGR of 7.3% during the forecast period 2016 - 2022.

 

Mechanical Thrombectomy is a sort of minimally-obtrusive methodology where an interventional radiologist utilizes specific equipment to eliminate a clot from a patient's artery. Thrombectomy Devices are being used to eliminate clots from a vein which is performed by an interventional system. 

 

It is generally used as a last resort as persistent blockage of blood flow to organs can prompt a circumstance known as necrosis. During a procedure, these devices will limit the harm to the vessel wall. Thrombectomy devices are also utilized to treat deep vein thrombosis, pneumonic embolism, neurovascular thrombosis conditions, and peripheral blood vessels as per the size and distance across and relying upon the affected area. The balloon embolectomy, aspiration embolectomy, and surgical embolectomy are the most regularly utilized Thrombectomy device strategies.

 

Global Mechanical Thrombectomy Devices market report offers strategic visions into the global Mechanical Thrombectomy Devices market and the market size (Volume – Million Tons and Revenue – US$ Billion) and estimates for the duration of 2017 to 2028. The research study covers in-depth analysis of multiple market segments based on application, end-user, study across different topographies. The report includes competitive profiling of the leading mechanical thrombectomy device vendors and the latest developments.

 

As indicated by the World Health Organization (WHO), chronic diseases are the leading causes of death and disability worldwide. Sickness rates from these conditions are speeding up significantly under hectic timetables, inactive ways of life, rising consumption of fast food, and the expanding number of individuals who smoke and consume alcohol. 

 

It addresses one of the key elements propelling the growth of the thrombectomy devices market around the world. Besides, the developing geriatric populace, alongside the escalating demand for minimally intrusive (MI) procedures and improving medical services found in different nations, is likewise fueling the development of the market. 

 

Moreover, due to expanding competition, the leading manufacturers are increasing their investments in research and development exercises to present mechanically progressed thrombectomy devices, which makes a positive perspective for the market. Besides this, favourable clinical reimbursements and the rising inclination of these devices by specialists for performing image-guided medical procedures are expected to strengthen the market development.

 

Nonetheless, the absence of trained experts and the complicated utilization of these devices restrict market development. The high expense related to the thrombectomy devices is hampering the market growth. Moreover, the absence of awareness about peripheral vascular illnesses in arising countries is challenging the market development.

 

In some cases, Deep vein thrombosis and pneumonic embolism remain underdiagnosed and prompt severe medical issues, which can avoid by getting away from the inactive way of life and making awareness. Mechanical thrombectomy devices include a vast number of endovascular devices cleared for eliminating thrombi from the neuro vasculature in intense ischemic stroke patients. There is a critical level of the stroke patient populace who are qualified for treatment with thrombolysis. 

 

According to the NHS England commissionary policy announced in 2018, about 12% of all people with stroke are qualified for mechanical thrombectomy techniques. Mechanical thrombectomy is perhaps the most utilized way to deal with recanalization in patients with large-artery occlusion who have not reacted to intravenous fibrinolysis. The demand is projected to be consistently developing. It should be a significant part of the thrombectomy devices market due to its excellent achievement rate in decreasing stroke-related handicap and mortality. Mechanical Thrombectomy Devices

The global mechanical Thrombectomy devices are segmented based On

  • Application
  • End-user
  • Region

 

Based on application, the global market is segmented into

  • Cardiovascular
  • Neurovascular
  • Peripheral vascular applications

 

Based on end-user, the global market is segmented into

  • Hospitals and surgical centres
  • Ambulatory care centres
  • Research laboratories 
  • Academic institutes 

 

In terms of application

The peripheral vascular segment is expected to be the quickest growing in the market during the forecast period. This development can be credited to the rising accessibility of clinical repayments for peripheral thrombectomy procedures across significant business sectors, rising occurrence of vascular disorders across the globe, developing geriatric populace, progressing innovative advancements in the field of vascular ultrasound treatment, and rising awareness related to the clinical adequacy of thrombectomy methodology in PVD treatment.

 

In terms of end-user

The hospitals and surgical centres segment represented the largest share of the global thrombectomy devices market in 2017. The considerable percentage of this segment is attributed to the growing adoption of stent and cluster retrievers for intense ischemic stroke therapy, expansion in clinical uses of ultrasonic thrombectomy for peripheral vascular therapy, rising frequency of chronic vascular diseases, and a growing number of hospitals and surgical centres across arising countries.

 

Based on geography, the global allergy rhinitis drugs market has been segmented into 

  • North America
  • Europe
  • Asia Pacific 
  • Latin America
  • Middle East & Africa

 

North America comprises the U.S.

  • Canada
  • Mexico

 

Europe would primarily cover Germany

  • France
  • UK
  • Italy 
  • Rest of Europe

 

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific. 

 

In Latin America, Brazil, Argentina, and the Rest of Latin America are the key segments whereas, in the Middle East & Africa, South Africa and the Rest of MEA are the key segments covered in the report.

 

North America held the most significant share in the worldwide thrombectomy device market in 2019 due to numerous innovatively progressed thrombectomy devices present around there. Factors, for example, the expanding adoption of innovatively progressed thrombectomy products among specialists, the developing number of clinical preliminaries, and clinical repayments accessible in the U.S. for thrombectomy systems are driving the development of the North American thrombectomy devices market. 

 

Asia-Pacific is projected to enlist the most noteworthy CAGR during the conjecture time frame.

 

The key players in the global market are 

  • Stryker Corp.
  • Medtronic Plc
  • Teleflex Inc.
  • Terumo Corp.
  • Penumbra Inc.
  • Boston Scientific Corp.
  • Acandis GmbH
  • Johnson and Johnson
  • AngioDynamics Inc.
  • Argon Medical Devices Inc. 

 

 

Global Mechanical Thrombectomy Devices Market Growth, Trend and Forecast 2021-2027

Chapter 1 Mechanical Thrombectomy Devices Market Overview
1.1 Product Overview and Scope of Mechanical Thrombectomy Devices
1.2 Mechanical Thrombectomy Devices Market Segmentation by Type
1.2.1 Global Production Market Share of Mechanical Thrombectomy Devices by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Mechanical Thrombectomy Devices Market Segmentation by Application
1.3.1 Mechanical Thrombectomy Devices Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Mechanical Thrombectomy Devices Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Mechanical Thrombectomy Devices (2014-2027)

Chapter 2 Global Economic Impact on Mechanical Thrombectomy Devices Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Mechanical Thrombectomy Devices Market Competition by Manufacturers
3.1 Global Mechanical Thrombectomy Devices Production and Share by Manufacturers (2020 and 2020)
3.2 Global Mechanical Thrombectomy Devices Revenue and Share by Manufacturers (2020 and 2020)
3.3 Global Mechanical Thrombectomy Devices Average Price by Manufacturers (2020 and 2020)
3.4 Manufacturers Mechanical Thrombectomy Devices Manufacturing Base Distribution, Production Area and Product Type
3.5 Mechanical Thrombectomy Devices Market Competitive Situation and Trends
3.5.1 Mechanical Thrombectomy Devices Market Concentration Rate
3.5.2 Mechanical Thrombectomy Devices Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Mechanical Thrombectomy Devices Production, Revenue (Value) by Region (2014-2021)
4.1 Global Mechanical Thrombectomy Devices Production by Region (2014-2021)
4.2 Global Mechanical Thrombectomy Devices Production Market Share by Region (2014-2021)
4.3 Global Mechanical Thrombectomy Devices Revenue (Value) and Market Share by Region (2014-2021)
4.4 Global Mechanical Thrombectomy Devices Production, Revenue, Price and Gross Margin (2014-2021)
4.5 North America Mechanical Thrombectomy Devices Production, Revenue, Price and Gross Margin (2014-2021)
4.6 Europe Mechanical Thrombectomy Devices Production, Revenue, Price and Gross Margin (2014-2021)
4.7 China Mechanical Thrombectomy Devices Production, Revenue, Price and Gross Margin (2014-2021)
4.8 Japan Mechanical Thrombectomy Devices Production, Revenue, Price and Gross Margin (2014-2021)
4.9 Southeast Asia Mechanical Thrombectomy Devices Production, Revenue, Price and Gross Margin (2014-2021)
4.10 India Mechanical Thrombectomy Devices Production, Revenue, Price and Gross Margin (2014-2021)

Chapter 5 Global Mechanical Thrombectomy Devices Supply (Production), Consumption, Export, Import by Regions (2014-2021)
5.1 Global Mechanical Thrombectomy Devices Consumption by Regions (2014-2021)
5.2 North America Mechanical Thrombectomy Devices Production, Consumption, Export, Import by Regions (2014-2021)
5.3 Europe Mechanical Thrombectomy Devices Production, Consumption, Export, Import by Regions (2014-2021)
5.4 China Mechanical Thrombectomy Devices Production, Consumption, Export, Import by Regions (2014-2021)
5.5 Japan Mechanical Thrombectomy Devices Production, Consumption, Export, Import by Regions (2014-2021)
5.6 Southeast Asia Mechanical Thrombectomy Devices Production, Consumption, Export, Import by Regions (2014-2021)
5.7 India Mechanical Thrombectomy Devices Production, Consumption, Export, Import by Regions (2014-2021)

Chapter 6 Global Mechanical Thrombectomy Devices Production, Revenue (Value), Price Trend by Type
6.1 Global Mechanical Thrombectomy Devices Production and Market Share by Type (2014-2021)
6.2 Global Mechanical Thrombectomy Devices Revenue and Market Share by Type (2014-2021)
6.3 Global Mechanical Thrombectomy Devices Price by Type (2014-2021)
6.4 Global Mechanical Thrombectomy Devices Production Growth by Type (2014-2021)

Chapter 7 Global Mechanical Thrombectomy Devices Market Analysis by Application
7.1 Global Mechanical Thrombectomy Devices Consumption and Market Share by Application (2014-2021)
7.2 Global Mechanical Thrombectomy Devices Consumption Growth Rate by Application (2014-2021)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Mechanical Thrombectomy Devices Manufacturing Cost Analysis
8.1 Mechanical Thrombectomy Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Mechanical Thrombectomy Devices

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Mechanical Thrombectomy Devices Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Mechanical Thrombectomy Devices Major Manufacturers in 2020
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global Mechanical Thrombectomy Devices Market Forecast (2021-2027)
12.1 Global Mechanical Thrombectomy Devices Production, Revenue Forecast (2021-2027)
12.2 Global Mechanical Thrombectomy Devices Production, Consumption Forecast by Regions (2021-2027)
12.3 Global Mechanical Thrombectomy Devices Production Forecast by Type (2021-2027)
12.4 Global Mechanical Thrombectomy Devices Consumption Forecast by Application (2021-2027)
12.5 Mechanical Thrombectomy Devices Price Forecast (2021-2027)

Chapter 13 Appendix

 

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is Mechanical Thrombectomy Devices?

Mechanical Thrombectomy is a sort of minimally-obtrusive methodology where an interventional radiologist utilizes specific equipment to eliminate a clot from a patient's artery. Thrombectomy Devices are being used to eliminate clots from a vein which is performed by an interventional system.

What is the Mechanical Thrombectomy Devices market share?

Global Mechanical Thrombectomy Devices Market was valued at USD 982 million in 2016. This value is projected to reach USD 1.38 billion by 2022 at a growing CAGR of 7.3% during the forecast period 2016 - 2022.

What are the key factors driving the Mechanical Thrombectomy Devices Market?

Due to expanding competition, the leading manufacturers are increasing their investments in research and development exercises to present mechanically progressed thrombectomy devices, which makes a positive perspective for the market. Besides this, favourable clinical reimbursements and the rising inclination of these devices by specialists for performing image-guided medical procedures are expected to strengthen the market development.

What are the top companies in the Mechanical Thrombectomy Devices Market?

Stryker Corp., Medtronic Plc, Teleflex Inc., Terumo Corp., Penumbra Inc., Boston Scientific Corp., Acandis GmbH, Johnson and Johnson, AngioDynamics Inc., Argon Medical Devices Inc.

Which regional segment dominated the global Mechanical Thrombectomy Devices market?

North America held the most significant share in the worldwide thrombectomy device market in 2019 due to numerous innovatively progressed thrombectomy devices present around there.

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Mechanical Thrombectomy Devices Market Size, Share...

RD Code : HP22